July 2014 FDA Recall Losartan Potassium And Hydrochlorothiazide by Jubilant Cadista Pharmaceuticals Inc.
D-1500-2014 - Presence of Foreign Substance

This Class II drug recall was voluntarily initiated by Jubilant Cadista Pharmaceuticals Inc. on July 11, 2014 for the product Losartan Potassium And Hydrochlorothiazide. The FDA reported the reason for recall as presence of foreign substance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1500-2014

Reason for Recall
Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.
Initiated
07-11-2014
Reported
08-06-2014
Quantity
9,358 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Jubilant Cadista Pharmaceuticals Inc.
Nationwide and Puerto Rico
Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, 90-tablets per bottle, Rx Only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC # 59746-339-90

Batch or Lot Expiration Information

Lot# 14P0292, Exp 04/2016